10 AI-generated high-yield questions by our AI engine
Overview & Pathophysiology
Avascular necrosis (AVN) of the femoral head — also termed osteonecrosis — results from interruption of the blood supply to the femoral head, leading to death of bone and marrow cells, subchondral fracture, and ultimately articular collapse. It is a devastating condition disproportionately affecting working-age adults (peak 30–50 years), and bilateral involvement occurs in up to 80% of cases depending on aetiology. Early diagnosis and stage-appropriate treatment are essential to prevent or delay femoral head collapse and the need for arthroplasty.
Aetiology: the most common causes are corticosteroid use (most common non-traumatic cause — dose-dependent; mechanism is fat cell hypertrophy causing intraosseous pressure rise and ischaemia + direct osteocyte toxicity + fat emboli), alcohol excess, and trauma (displaced femoral neck fracture, hip dislocation — damage to the retinacular vessels); other causes include sickle cell disease (vascular occlusion), systemic lupus erythematosus, diving/dysbaric osteonecrosis (nitrogen bubble formation), Gaucher disease, radiation, coagulopathy
Pathophysiology: intraosseous ischaemia → osteocyte and marrow cell death → structural bone weakening → repetitive loading leads to subchondral fracture (crescent sign) → articular surface collapse → secondary osteoarthritis of the hip
The anterosuperior segment of the femoral head is the most commonly and severely affected area — it bears the greatest mechanical load and has the most tenuous blood supply (terminal branches of the lateral epiphyseal vessels); the degree of involvement of this weight-bearing segment determines the prognosis
Ficat & Arlet Classification
The Ficat and Arlet classification (1980) is the original and most historically important staging system for femoral head AVN, based on plain radiographic and clinical findings.
Stage
Clinical Features
Radiological Findings
Stage I
Hip pain; normal X-ray; abnormal MRI
Normal plain radiograph; MRI shows characteristic double-line sign
Stage II
Hip pain
Sclerosis and/or cystic changes in the femoral head; no collapse; head shape maintained; first radiographically visible stage
Stage III
Pain, restricted movement
Subchondral fracture (crescent sign on the frog-leg lateral view); early flattening of the femoral head; joint space maintained
Stage IV
Severe pain, significant restriction
Articular collapse; flattening of the femoral head; joint space narrowing; secondary OA changes in the acetabulum
ARCO Classification (International)
The ARCO (Association Research Circulation Osseous) classification is the most widely used modern staging system, incorporating MRI findings and quantifying the extent of femoral head involvement. It supersedes Ficat for clinical decision-making.
ARCO Stage
Description
Imaging
Stage 0
No symptoms; all imaging normal; biopsy diagnosis only
Normal X-ray, MRI, bone scan
Stage I
Normal X-ray; abnormal MRI/bone scan; no collapse
MRI: double-line sign (pathognomonic) — inner high T2 signal line (granulation tissue) + outer low signal line (sclerotic border) on T2-weighted MRI; X-ray normal
Stage II
Sclerosis/cysts on X-ray; no collapse; head spherical
Sclerosis and cysts visible on X-ray; MRI confirms extent; no crescent sign; head shape maintained
Stage III
Subchondral fracture (crescent sign); early collapse (<2 mm); joint space maintained; the critical transition stage
Crescent sign on frog-leg lateral view; CT shows subchondral fracture clearly; collapse <2 mm; acetabulum normal
Stage IV
Femoral head collapse >2 mm; joint space maintained; acetabulum normal
Flattening and collapse of femoral head; acetabular cartilage still intact
Stage V
Joint space narrowing; OA changes in the acetabulum
Secondary OA; acetabular changes; joint space loss
Double-line sign on MRI: pathognomonic of AVN of the femoral head; seen on T2-weighted MRI; the inner bright (high signal) line represents reactive granulation tissue (hyperaemia); the outer dark (low signal) line represents the sclerotic margin of the necrotic zone; this sign at the interface between living and dead bone is specific for AVN and distinguishes it from other causes of hip pain
Crescent sign: a subchondral lucency visible on the frog-leg lateral view of the hip; represents separation of the dead subchondral bone from the overlying articular cartilage (subchondral fracture); marks the transition from Stage II to Stage III ARCO; its appearance indicates that femoral head collapse is imminent or has begun; best seen on frog-leg lateral view, also visible on CT
Investigations
MRI: the gold standard investigation for early AVN (Stages 0–II); sensitivity and specificity approaching 99%; the double-line sign is pathognomonic; MRI also quantifies the size of the necrotic lesion (as a percentage of femoral head volume) and its location (anterosuperior = worst prognosis); mandatory bilateral MRI — up to 80% bilateral involvement
Plain radiographs (AP pelvis and frog-leg lateral): normal in early disease; sclerosis and cysts in Stage II; crescent sign in Stage III; collapse in Stage IV; essential for staging and planning; always include a frog-leg lateral to assess for the crescent sign
CT: excellent for quantifying the degree of femoral head collapse and the extent of subchondral fracture; useful pre-operatively for surgical planning; identifies the crescent sign reliably
Bone scintigraphy (technetium-99m): historically used; "cold-in-hot" pattern (cold photopenic area within an area of increased uptake); superseded by MRI for diagnosis
Blood tests: FBC, ESR, CRP (exclude infection and inflammatory arthritis); thrombophilia screen; fasting lipids; coagulation screen where haematological aetiology is suspected
Management
ARCO Stage
Management Options
Stage I–II (pre-collapse)
Core decompression ± bone grafting ± biological adjuncts (BMP, MSC); protected weight-bearing; bisphosphonates (limited evidence); address underlying cause (reduce steroids if possible)
Stage III (subchondral fracture, early collapse)
Core decompression with structural support (fibular strut graft or tantalum rod) — if collapse <2 mm and necrotic volume <30%; THA for older patients or larger lesions; osteotomy (rotational osteotomy — Sugioka procedure) in selected young patients to rotate necrotic segment away from weight-bearing zone
Stage IV–V (collapse, OA)
Total hip arthroplasty (THA); the definitive treatment for advanced AVN with collapse; outcomes of THA in AVN are generally good but inferior to primary OA THA due to younger patient age and higher revision rates over time
Core decompression: the primary joint-preserving intervention for pre-collapse AVN (ARCO I–II, selected Stage III); multiple drill holes or a single core tract decompresses the elevated intraosseous pressure, promotes revascularisation, and may halt disease progression; success rates of approximately 70–80% in Stage I, 60–70% in Stage II, significantly lower in Stage III; can be supplemented with bone grafting (structural allograft, vascularised fibular graft) to provide mechanical support
Vascularised fibular graft (FVFG): a vascularised segment of the fibula is harvested with its peroneal vessel pedicle and inserted into the core decompression channel; provides both mechanical support and vascular supply to the necrotic zone; the most biologically effective joint-preserving procedure; technically demanding microsurgical procedure; results superior to simple core decompression in Stage II–III in specialist centres
Consultant-Level Considerations
Necrotic volume and prognosis: the size and location of the necrotic lesion on MRI is the most important prognostic factor for progression to collapse; lesions involving <15% of the femoral head volume (small lesion) have an excellent prognosis with or without treatment; lesions >30% (large lesion) involving the weight-bearing anterosuperior segment have a very high rate of progression to collapse; the Kerboul combined necrotic angle (>200° = large lesion, high risk) is a validated quantitative MRI measure used in treatment decisions
Steroid-induced AVN — dose and risk: the risk of AVN increases with cumulative steroid dose and with pulse high-dose intravenous steroids; a single short course of oral steroids has minimal risk; patients on prolonged corticosteroids (e.g., post-transplant, rheumatological disease, haematological malignancy) should be counselled about AVN risk; early MRI should be performed in steroid-treated patients presenting with hip pain
THA in AVN — specific technical considerations: AVN patients tend to be younger than primary OA patients; ceramic-on-ceramic bearing surfaces are preferred (maximise longevity, avoid polyethylene wear in a young high-demand patient); uncemented fixation preferred (press-fit acetabular shell + cementless femoral stem); the femoral head in late AVN is often collapsed and irregular — correct femoral head centre restoration is important; the acetabulum is usually spared until very late (Stage V) — acetabular bone stock is generally normal
Sugioka transtrochanteric rotational osteotomy: a technically demanding procedure in which the femoral head is rotated to bring the posterior non-necrotic cartilage into the weight-bearing position; can delay or avoid THA in selected young patients with anterosuperior AVN and an intact posterior segment; requires careful pre-operative MRI assessment to confirm adequate viable posterior cartilage; results are technique-sensitive and operator-dependent
Exam Pearls
MRI double-line sign: pathognomonic of AVN; T2-weighted; inner high signal (granulation) + outer low signal (sclerosis); ARCO Stage I–II; bilateral MRI mandatory (up to 80% bilateral)
Crescent sign: subchondral lucency on frog-leg lateral view; subchondral fracture; ARCO Stage III; collapse is imminent
Most common non-traumatic cause: corticosteroid use; mechanism — fat cell hypertrophy + intraosseous pressure rise + direct osteocyte toxicity; dose-dependent
ARCO I–II (pre-collapse): core decompression ± grafting; joint-preserving; ~70–80% success in Stage I; lower in Stage III
Necrotic volume >30% of femoral head + anterosuperior location = high risk of collapse; Kerboul angle >200° = large lesion; THA likely required regardless of joint-preserving attempt
Vascularised fibular graft: most effective joint-preserving procedure; provides mechanical support AND vascular supply; technically demanding; specialist centres
ARCO IV–V (collapse/OA): THA; ceramic-on-ceramic preferred in young AVN patients; uncemented fixation; acetabulum usually spared until late
Ficat vs ARCO: Ficat I–IV (plain X-ray based); ARCO 0–V (MRI incorporated, lesion quantification); ARCO is the modern standard
Anterosuperior segment: most commonly affected; highest mechanical load; most tenuous blood supply; most important for prognosis
Bilateral disease: up to 80% bilateral involvement; always image both hips; stagger treatment if both require intervention
10 AI-generated high-yield questions by our AI engine
References
Ficat RP. Idiopathic bone necrosis of the femoral head. J Bone Joint Surg Br. 1985;67(1):3–9.
ARCO (Association Research Circulation Osseous). Committee on Terminology and Classification. ARCO News. 1992;4:41–46.
Mont MA et al. Nontraumatic osteonecrosis of the femoral head. J Bone Joint Surg Am. 2006;88(5):1117–1132.
Steinberg ME et al. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77(1):34–41.
Urbaniak JR, Harvey EJ. Revascularization of the femoral head with free vascularized fibular grafting. Clin Orthop Relat Res. 1998;(347):230–250.
Agarwala S et al. Use of alendronate in the treatment of avascular necrosis of the femoral head. J Arthroplasty. 2005.
Campbells Operative Orthopaedics. 14th Edition. Elsevier.
Orthobullets — Osteonecrosis of the Femoral Head.
Kerboul M et al. The conservative surgical treatment of idiopathic aseptic necrosis of the femoral head. J Bone Joint Surg Br. 1974;56(2):291–296.
Gardeniers JW. The ARCO perspective for reaching one uniform staging system of osteonecrosis. ARCO News. 1992.